© 2025 All Rights reserved WUSF
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
WUSF's Wake Up Call
Our daily newsletter, delivered first thing weekdays, keeps you connected to your community with news, culture, national NPR headlines, and more.
Subscribe

Patients turn to 'gray market' for cheaper obesity drugs, but it's risky

By Sydney Lupkin
Published October 7, 2025 at 5:05 PM EDT

Patients who want a deeper discount on obesity meds than compounding pharmacies can offer are turning to the gray market, where they buy the raw active ingredient from China and prepare it themselves.

Copyright 2025 NPR
Tags
US / WorldNPR HealthAll Things Considered
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin
Thanks to you, WUSF is here — delivering fact-based news and stories that reflect our community.⁠ Your support powers everything we do.
Donate Now